adamantane has been researched along with Edema in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (7.69) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, Q; He, N; Li, JY; Sun, T; Sun, YL; Wang, R; Yu, J; Zeng, Q; Zhang, XY; Zhuang, Y | 1 |
| Cayasso, M; László, JF; Pórszász, R; Szalai, A; Újhelyi, J; Újhelyi, Z; Vecsernyés, M | 1 |
| Coughtrie, AL; Layton, D; Qayum, N; Shakir, SA | 1 |
| Bentley, P; Busch, S; Gunson, D; Hayes, M; Hoffmann, P; Keselica, M; Lapadula, D; Martin, L; Skuba, E | 1 |
| Mikhail, N | 1 |
| Maldonado-Lutomirsky, M; Niggli, M; Rosenstock, J | 1 |
| Bolli, G; Colin, L; Dotta, F; Goodman, M; Minic, B | 1 |
| Donahue, H; Fitzpatrick, LR; Frauenhoffer, EE; French, KJ; Green, C; Maines, LW; Mosher, TJ; Paul, E; Smith, CD; Upson, JJ; Zhuang, Y | 1 |
| Baron, MA; Dejager, S; Mills, D; Rosenstock, J; Schweizer, A | 1 |
| Boss, H; Hatzelmann, A; Sterk, GJ; Timmerman, H; Van der Laan, IJ; Van der Mey, M | 1 |
| Boss, H; Couwenberg, D; Goubitz, K; Hatzelmann, A; Schenk, H; Sterk, GJ; Timmerman, H; Van der Mey, M | 1 |
| el-Emam, AA; Ibrahim, TM | 1 |
| Bekemeier, H; Funke, T; Giessler, AJ; Hänsel, F; Hirschelmann, R; Krause, E; Langner, A; Schmidt, K; Schumann, HH; Zarnack, S | 1 |
1 review(s) available for adamantane and Edema
| Article | Year |
|---|---|
Combination therapy with DPP-4 inhibitors and pioglitazone in type 2 diabetes: theoretical consideration and therapeutic potential.
Topics: Adamantane; Blood Glucose; Body Weight; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Edema; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Lipids; Nitriles; Pioglitazone; Pyrazines; Pyrrolidines; Sitagliptin Phosphate; Thiazolidinediones; Treatment Outcome; Triazoles; Vildagliptin | 2008 |
2 trial(s) available for adamantane and Edema
| Article | Year |
|---|---|
Comparison of vildagliptin and pioglitazone in patients with type 2 diabetes inadequately controlled with metformin.
Topics: Adamantane; Adolescent; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Edema; Fasting; Female; Glycated Hemoglobin; Humans; Hypoglycemia; Hypoglycemic Agents; Male; Metformin; Middle Aged; Nitriles; Pioglitazone; Pyrrolidines; Thiazolidinediones; Treatment Outcome; Vildagliptin; Weight Gain; Young Adult | 2009 |
Comparison of vildagliptin and rosiglitazone monotherapy in patients with type 2 diabetes: a 24-week, double-blind, randomized trial.
Topics: Adamantane; Aged; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Edema; Female; Humans; Hypoglycemic Agents; Male; Middle Aged; Nitriles; Pyrrolidines; Racial Groups; Rosiglitazone; Thiazolidinediones; Vildagliptin | 2007 |
10 other study(ies) available for adamantane and Edema
| Article | Year |
|---|---|
The anti-inflammatory potential of neuropeptide FF in vitro and in vivo.
Topics: Adamantane; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Cell Line; Dipeptides; Edema; Gene Expression Regulation; Lipopolysaccharides; Macrophages, Peritoneal; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase Type II; Oligopeptides; Primary Cell Culture; Protein Transport; Pyrrolidines; Receptors, Neuropeptide; Signal Transduction; Thiocarbamates | 2013 |
Analgesic and anti-inflammatory effectiveness of sitagliptin and vildagliptin in mice.
Topics: Adamantane; Allyl Compounds; Analgesics; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis; Capsaicin; Disease Models, Animal; Dose-Response Relationship, Drug; Edema; Freund's Adjuvant; Isothiocyanates; Male; Mice; Nitriles; Pyrrolidines; Sitagliptin Phosphate; Temperature; Urinary Bladder; Vildagliptin | 2014 |
Pattern of Onset and Risk Factors for Peripheral Oedema During Vildagliptin Use: Analysis from the Vildagliptin Prescription-Event Monitoring Study in England.
Topics: Adamantane; Aged; Cohort Studies; Edema; England; Female; Humans; Male; Middle Aged; Nitriles; Prescription Drug Monitoring Programs; Pyrrolidines; Sex Factors; Vildagliptin | 2016 |
Acute Toxicity of Vildagliptin.
Topics: Adamantane; Administration, Oral; Animals; Dipeptidyl-Peptidase IV Inhibitors; Edema; Female; Macaca fascicularis; Male; Nitriles; Pyrrolidines; Species Specificity; Toxicity Tests, Acute; Vasoconstriction; Vildagliptin | 2017 |
Long-term 2-year safety and efficacy of vildagliptin compared with rosiglitazone in drug-naïve patients with type 2 diabetes mellitus.
Topics: Adamantane; Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Double-Blind Method; Edema; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Male; Middle Aged; Nitriles; Pyrrolidines; Rosiglitazone; Thiazolidinediones; Treatment Outcome; Vildagliptin; Weight Gain | 2009 |
Attenuation of arthritis in rodents by a novel orally-available inhibitor of sphingosine kinase.
Topics: Adamantane; Administration, Oral; Animals; Ankle; Ankle Joint; Arthritis, Experimental; Body Weight; Drug Therapy, Combination; Edema; Enzyme Inhibitors; Female; Foot; Indomethacin; Inflammation; Methotrexate; Mice; Mice, Inbred DBA; Phosphotransferases (Alcohol Group Acceptor); Pyridines; Rats; Rats, Inbred Lew; Splenomegaly; X-Ray Microtomography | 2011 |
Novel selective PDE4 inhibitors. 3. In vivo antiinflammatory activity of a new series of N-substituted cis-tetra- and cis-hexahydrophthalazinones.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adamantane; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclic Nucleotide Phosphodiesterases, Type 4; Cycloheptanes; Edema; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Leukocytes, Mononuclear; Lipopolysaccharides; Luminescent Measurements; Mice; Phthalazines; Reactive Oxygen Species; Structure-Activity Relationship; Tumor Necrosis Factor-alpha | 2002 |
Novel selective phosphodiesterase (PDE4) inhibitors. 4. Resolution, absolute configuration, and PDE4 inhibitory activity of cis-tetra- and cis-hexahydrophthalazinones.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adamantane; Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Benzoates; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Edema; Enzyme Inhibitors; Female; Humans; In Vitro Techniques; Mice; Molecular Conformation; Neutrophils; Phthalazines; Stereoisomerism; Structure-Activity Relationship | 2002 |
Synthesis and anti-inflammatory and analgesic activity of some 3-(1-adamantyl)-4-substituted-5-mercapto-1,2,4-triazoles.
Topics: Adamantane; Animals; Anti-Inflammatory Agents, Non-Steroidal; Carrageenan; Dose-Response Relationship, Drug; Edema; Lethal Dose 50; Magnetic Resonance Spectroscopy; Male; Mice; Pain Measurement; Rats; Sulfhydryl Compounds; Triazoles | 1991 |
[The pharmacology of the lipoxygenase inhibitors oxphaman (1-(2,5-dihydroxybenzylidene)aminoadamantane) and oxphalin (1-(3,4-dihydroxybenzylidene)-2,4,6-trimethylaniline].
Topics: Adamantane; Aniline Compounds; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Experimental; Asthma; Benzyl Compounds; Edema; Free Radicals; Glycine max; Guinea Pigs; Histamine Antagonists; In Vitro Techniques; Lipoxygenase Inhibitors; Male; Mice; Reticulocytes; Skin Absorption | 1989 |